The significance of IL-17A, CRP and IL-6 suggests that not just Th-2 or Th-17 cells are important in lung cancer progression and supports our hypothesis that the inclusion of a broader cytokine panel can capture the multi-faceted role of inflammation in lung cancer. The gene discussed is IL17A; the disease is lung cancer.